EDIL3-DT

Across TCGA pan-cancer cohorts, EDIL3-DT RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of EDIL3-DT’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where EDIL3-DT RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EDIL3-DT is over-expressed in tumor, although a few such as COAD and KICH show the opposite, repressed pattern.

KIRP, COAD, and KICH are the cancer types where EDIL3-DT tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EDIL3-DT RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Female	II,III,IV	+2.276	<.001	11	view →
COAD	All	IV	−1.077	<.001	11	view →
KICH	Male	All	−1.170	<.001	10	view →
KIRC	All	III,IV	+0.706	<.001	10	view →
HNSC	All	All	+0.530	<.001	9	view →
LIHC	All	All	+0.118	<.001	8	view →
READ	All	All	−1.278	<.001	7	view →
THCA	Female	All	+0.264	<.001	6	view →
UCEC	All	All	−0.486	.001	4	view →
LUSC	All	III,IV	−0.778	.007	3	view →
PAAD	All	All	+1.162	.046	2	view →
PRAD	All	All	−0.403	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

EDIL3-DT–KIRP

Open the KIRP breakdown →